- Home
- CDLX
CDLX
Cardlytics Inc.
as 07-26-2024 4:00pm EST
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K., and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | ATLANTA |
| Market Cap: | 432.7M | IPO Year: | 2018 |
| Target Price: | $12.67 | AVG Volume (30 days): | 635.2K |
| Analyst Decision: | Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.60 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.71 - $20.52 | Next Earning Date: | 08-07-2024 |
| Revenue: | $312,481,000 | Revenue Growth: | 5.95% |
| Revenue Growth (this year): | 5.41% | Revenue Growth (next year): | 13.97% |
Stock Insider Trading Activity of Cardlytics Inc. (CDLX)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Gupta Amit | CDLX | Chief Operating Officer | Jul 1 '24 | Sell | $7.95 | 7,507 | $59,703.17 | 129,518 | SEC Form 4 |
| DeSieno Alexis | CDLX | Chief Financial Officer | Jul 1 '24 | Sell | $7.95 | 7,451 | $59,257.80 | 6,898 | SEC Form 4 |
| Lynton Nicholas Hollmeyer | CDLX | Chief Legal & Privacy Officer | Jul 1 '24 | Sell | $7.95 | 5,956 | $47,368.07 | 78,593 | SEC Form 4 |
| Temsamani Karim Saad | CDLX | Chief Executive Officer | Jun 1 '24 | Sell | $8.66 | 43,129 | $373,281.50 | 385,530 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | May 9 '24 | Buy | $8.73 | 225,000 | $1,963,687.50 | 6,361,113 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | May 9 '24 | Buy | $8.79 | 100,000 | $878,540.00 | 6,461,113 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | May 9 '24 | Buy | $8.99 | 3,746 | $33,661.56 | 6,464,859 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | May 9 '24 | Buy | $8.73 | 225,000 | $1,963,687.50 | 6,361,113 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | May 9 '24 | Buy | $8.79 | 100,000 | $878,540.00 | 6,461,113 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | May 9 '24 | Buy | $8.99 | 3,746 | $33,661.56 | 6,464,859 | SEC Form 4 |
| Gupta Amit | CDLX | Chief Operating Officer | Apr 23 '24 | Sell | $11.91 | 23,416 | $278,884.56 | 122,676 | SEC Form 4 |
| Lynton Nicholas Hollmeyer | CDLX | Chief Legal & Privacy Officer | Apr 22 '24 | Sell | $12.76 | 276 | $3,521.21 | 71,761 | SEC Form 4 |
| Temsamani Karim Saad | CDLX | Chief Executive Officer | Apr 1 '24 | Sell | $13.69 | 32,564 | $445,801.16 | 344,734 | SEC Form 4 |
| Temsamani Karim Saad | CDLX | Chief Executive Officer | Apr 1 '24 | Sell | $14.41 | 154 | $2,219.14 | 344,580 | SEC Form 4 |
| Lynton Nicholas Hollmeyer | CDLX | Chief Legal & Privacy Officer | Apr 1 '24 | Sell | $13.69 | 12,401 | $169,769.69 | 71,414 | SEC Form 4 |
| Lynton Nicholas Hollmeyer | CDLX | Chief Legal & Privacy Officer | Apr 1 '24 | Sell | $14.41 | 59 | $850.19 | 71,355 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | Mar 19 '24 | Buy | $14.16 | 350,000 | $4,956,035.00 | 6,373,676 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | Mar 15 '24 | Buy | $13.71 | 311,715 | $4,274,173.74 | 5,673,676 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | Mar 15 '24 | Buy | $13.40 | 350,000 | $4,689,685.00 | 6,023,676 | SEC Form 4 |
| Temsamani Karim Saad | CDLX | Chief Executive Officer | Mar 1 '24 | Sell | $7.89 | 34,515 | $272,323.35 | 327,298 | SEC Form 4 |
| Gupta Amit | CDLX | Chief Operating Officer | Jan 23 '24 | Sell | $6.10 | 72,658 | $443,286.46 | 102,342 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | Jan 12 '24 | Sell | $7.00 | 17,155 | $120,127.89 | 5,361,961 | SEC Form 4 |
| SOSIN CLIFFORD | CDLX | 10% Owner | Jan 2 '24 | Sell | $8.86 | 37,000 | $327,697.90 | 5,379,116 | SEC Form 4 |
| Temsamani Karim Saad | CDLX | Chief Executive Officer | Jan 1 '24 | Sell | $7.77 | 31,123 | $241,825.71 | 277,735 | SEC Form 4 |
| Lynton Nicholas Hollmeyer | CDLX | Chief Legal & Privacy Officer | Jan 1 '24 | Sell | $7.77 | 15,620 | $121,367.40 | 55,849 | SEC Form 4 |
Latest Cardlytics Inc. News
CDLX Breaking Stock News: Dive into CDLX Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Cardlytics Announces Timing of Its Second Quarter 2024 Earnings Release
Simply Wall St.
a month ago
With 63% ownership of the shares, Cardlytics, Inc. (NASDAQ:CDLX) is heavily dominated by institutional owners
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
PR Newswire
2 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
Business Wire
2 months ago
Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
AFP
2 months ago
New Zealand scraps plan to tax livestock burps, farts
Business Wire
2 months ago
InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA
The Wall Street Journal
2 months ago
ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility
Compare CDLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDLX Cardlytics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.